A 0 1 0 1 O
creatinine 2 12 2 12 B-clinical_variable
level 13 18 13 18 I-clinical_variable
of 19 21 19 21 O
less 22 26 22 26 O
than 27 31 27 31 O
1 32 33 32 33 B-upper_bound
1/2 34 37 34 37 I-upper_bound
times 38 43 38 43 I-upper_bound
the 44 47 44 47 I-upper_bound
upper 48 53 48 53 I-upper_bound
limit 54 59 54 59 I-upper_bound
of 60 62 60 62 I-upper_bound
normal 63 69 63 69 I-upper_bound
for 70 73 70 73 O
the 74 77 74 77 O
local 78 83 78 83 O
lab 84 87 84 87 O
test 88 92 88 92 O

At 0 2 93 95 O
least 3 8 96 101 O
part 9 13 102 106 O
of 14 16 107 109 O
the 17 20 110 113 O
lung 21 25 114 118 B-cancer
cancer 26 32 119 125 I-cancer
must 33 37 126 130 O
be 38 40 131 133 O
viewable 41 49 134 142 O
and 50 53 143 146 O
measurable 54 64 147 157 O
by 65 67 158 160 O
CT 68 70 161 163 O
or 71 73 164 166 O
MRI 74 77 167 170 O

Enrolled 0 8 171 179 O
in 9 11 180 182 O
another 12 19 183 190 O
therapeutic 20 31 191 202 B-treatment
clinical 32 40 203 211 I-treatment
trial 41 46 212 217 I-treatment

Exudative 0 9 218 227 B-cancer
pleural 10 17 228 235 I-cancer
effusion 18 26 236 244 I-cancer

Glucose-6 0 9 245 254 B-chronic_disease
- 9 10 254 255 I-chronic_disease
phosphate 10 19 255 264 I-chronic_disease
dehydrogenase 20 33 265 278 I-chronic_disease
( 34 35 279 280 I-chronic_disease
G6PD 35 39 280 284 I-chronic_disease
) 39 40 284 285 I-chronic_disease
deficiency 41 51 286 296 I-chronic_disease

Lactating 0 9 297 306 O
women 10 15 307 312 B-gender

Not 0 3 313 316 B-pregnancy
pregnant 4 12 317 325 I-pregnancy

Pathologic 0 10 326 336 O
diagnosis 11 20 337 346 O
( 21 22 347 348 O
i.e. 22 26 348 352 O
, 26 27 352 353 O
cell 28 32 354 358 O
sample 33 39 359 365 O
, 39 40 365 366 O
biopsy 41 47 367 373 B-treatment
, 47 48 373 374 O
tissue 49 55 375 381 B-treatment
swap 56 60 382 386 I-treatment
, 60 61 386 387 O
bronchoscopy 62 74 388 400 B-treatment
) 74 75 400 401 O
with 76 80 402 406 O
non 81 84 407 410 B-cancer
- 84 85 410 411 I-cancer
small 85 90 411 416 I-cancer
cell 91 95 417 421 I-cancer
lung 96 100 422 426 I-cancer
cancer 101 107 427 433 I-cancer

Patients 0 8 434 442 O
actively 9 17 443 451 O
receiving 18 27 452 461 O
insulin 28 35 462 469 B-treatment

Patients 0 8 470 478 O
requiring 9 18 479 488 O
daily 19 24 489 494 O
finger 25 31 495 501 B-clinical_variable
- 31 32 501 502 I-clinical_variable
stick 32 37 502 507 I-clinical_variable
blood 38 43 508 513 I-clinical_variable
glucose 44 51 514 521 I-clinical_variable
measurements 52 64 522 534 O

Physician 0 9 535 544 O
determined 10 20 545 555 O
the 21 24 556 559 O
patient 25 32 560 567 O
is 33 35 568 570 O
healthy 36 43 571 578 O
enough 44 50 579 585 O
for 51 54 586 589 O
chemotherapy 55 67 590 602 B-treatment
and 68 71 603 606 O
radiation 72 81 607 616 B-treatment
therapy 82 89 617 624 I-treatment

Recurrent 0 9 625 634 O
non 10 13 635 638 B-cancer
- 13 14 638 639 I-cancer
small 14 19 639 644 I-cancer
cell 20 24 645 649 I-cancer
lung 25 29 650 654 I-cancer
cancer 30 36 655 661 I-cancer

a 0 1 662 663 O
creatinine 2 12 664 674 B-clinical_variable
clearance 13 22 675 684 I-clinical_variable
of 23 25 685 687 O
at 26 28 688 690 O
least 29 34 691 696 O
60 35 37 697 699 B-lower_bound
mL/(min*1.73m2 38 52 700 714 I-lower_bound
) 52 53 714 715 I-lower_bound

amphetamines 0 12 716 728 B-treatment

chlorpropamide 0 14 729 743 B-treatment

commit 0 6 744 750 B-contraception_consent
to 7 9 751 753 I-contraception_consent
using 10 15 754 759 I-contraception_consent
birth 16 21 760 765 I-contraception_consent
control 22 29 766 773 I-contraception_consent
during 30 36 774 780 O
the 37 40 781 784 O
study 41 46 785 790 O

flecainide 0 10 791 801 B-treatment

quinidine 0 9 802 811 B-treatment

warfarin 0 8 812 820 B-treatment

